Overview

Brugada Syndrome is a rare inherited heart condition that affects the electrical system of the heart. It is characterized by a specific abnormal heart rhythm (arrhythmia) and a distinctive ECG (electrocardiogram) pattern. This condition can cause the heart to beat dangerously fast (ventricular tachycardia or ventricular fibrillation), which can lead to fainting, seizures, or even sudden cardiac death, particularly during rest or sleep.

 

Brugada Syndrome is more common in adult males and people of Asian descent, particularly those from Southeast Asia, though it can affect people of any gender, age, or ethnicity. It is estimated to affect about 1 in 2,000 people worldwide, but this may vary significantly across different populations.

 

Genetic Factors

Inherited Condition: Brugada Syndrome is often inherited in an autosomal dominant pattern, meaning that a child of an affected parent has a 50% chance of inheriting the condition.

​​

Genetic Mutations: The most common genetic cause is a mutation in the SCN5A gene, which provides instructions for making a sodium channel that transports positively charged sodium ions into heart muscle cells. However, mutations in this gene account for only about 20-30% of cases, and mutations in other genes can also cause the syndrome.​

 

Triggers and Risk Factors

Certain factors can trigger arrhythmias in people with Brugada Syndrome:​

 

Fever: Even a mild fever can trigger dangerous heart rhythms in affected individuals.

 

Certain Medications: Some drugs, including certain antiarrhythmic medications, antidepressants, and antihistamines, can trigger Brugada ECG patterns and symptoms.

​​

Electrolyte Imbalances: Abnormal levels of potassium, calcium, or sodium in the blood.

​​

Excessive Alcohol Consumption: Consuming large amounts of alcohol in a short period.​

 

Male Gender: Men are 8-10 times more likely to develop symptoms than women.​

 

Symptoms

Many people with Brugada Syndrome do not experience any symptoms and may be unaware they have the condition until it is detected during an ECG for another reason. When symptoms do occur, they may include:

​​

Fainting (Syncope): Typically occurring during rest or sleep.​

 

Seizures: Sometimes mistaken for epilepsy.

​​

Palpitations: Awareness of irregular or rapid heartbeats.

​​

Nocturnal Agonal Breathing: Gasping or difficulty breathing during sleep.​

 

Sudden Cardiac Arrest: In some cases, the first and only symptom may be sudden cardiac arrest, which can be fatal without immediate treatment.

​

Diagnosis

Diagnosing Brugada Syndrome involves several steps:

 

1. Electrocardiogram (ECG)

Characteristic Pattern: The hallmark of Brugada Syndrome is a specific ECG pattern characterized by a distinctive ST-segment elevation in the right precordial leads (V1-V3).

 

Spontaneous vs. Induced: The ECG pattern may be present spontaneously or may only appear under certain conditions (such as during fever or after taking certain medications).

 

2. Provocative Drug Challenge

Medication-Induced Testing: If Brugada Syndrome is suspected but not evident on a standard ECG, a sodium channel blocker medication (such as ajmaline, flecainide, or procainamide) may be administered under careful monitoring to unmask the ECG pattern.

 

3. Genetic Testing

Genetic Analysis: Testing for mutations in known Brugada-associated genes can help confirm the diagnosis and identify family members who may be at risk.

 

Additional Tests

1. Electrophysiological Study (EPS): This invasive test may be performed to assess the heart's electrical function and determine the risk of dangerous arrhythmias.

 

2. Family Screening: Once a diagnosis is made, family members should be evaluated given the hereditary nature of the condition.

​

Treatment Options

Treatment for Brugada Syndrome is focused on preventing dangerous arrhythmias and sudden cardiac death:

 

1. Implantable Cardioverter Defibrillator (ICD)

 

Primary Prevention: For high-risk patients who have not experienced cardiac arrest but have risk factors such as spontaneous type 1 ECG pattern, history of syncope, or family history of sudden cardiac death.

 

Secondary Prevention: For patients who have survived a cardiac arrest or experienced documented ventricular arrhythmias.

 

Continuous Protection: The ICD continuously monitors heart rhythm and delivers an electrical shock if a life-threatening arrhythmia is detected.

 

2. Medications

 

Quinidine: This medication can help reduce the frequency of arrhythmias in some patients.

 

Experimental Treatments: New medications and treatments are being researched, but their efficacy is still being evaluated.

​

3. Lifestyle Modifications

 

Fever Management: Prompt treatment of fever with antipyretics (fever-reducing medications) is important.

 

Medication Avoidance: Certain medications can exacerbate the condition and should be avoided. A complete list should be provided by your healthcare provider.

 

Electrolyte Balance: Maintaining proper hydration and electrolyte balance is important, especially during physical activity or illness.

 

Alcohol Moderation: Excessive alcohol consumption should be avoided.

 

Living with Brugada Syndrome

Physical Activity: Most individuals with Brugada Syndrome can participate in regular physical activities. However, competitive sports or extremely strenuous activities should be discussed with your healthcare provider.

 

Medical Alert: Consider wearing a medical alert bracelet or carrying information about your condition.

 

Regular Follow-up: Attend all scheduled follow-up appointments with your cardiologist.

 

Genetic Counselling: If you're planning a family, consider genetic counselling to understand the risks of passing the condition to your children.

 

Family Screening: Encourage close family members to be screened for the condition.

​

When to Seek Medical Attention

Contact your healthcare provider immediately or seek emergency care if you experience:

 

Fainting or Near-Fainting Episodes: Especially if they occur during rest or sleep.

 

Palpitations: Unusual awareness of your heartbeat or irregular heart rhythms.

 

Seizures: Particularly if they occur without a previous history of epilepsy.

 

Fever: If you develop a fever, seek medical attention promptly and inform healthcare providers of your Brugada Syndrome diagnosis.

 

ICD Shock: If you have an ICD and it delivers a shock, contact your healthcare provider or seek emergency care.

​

Conclusion

Brugada Syndrome is a complex cardiac condition that requires careful management and regular follow-up. While it can be a serious condition, many people with Brugada Syndrome lead normal, active lives with appropriate treatment and precautions. Working closely with a cardiologist who specializes in heart rhythm disorders is essential for optimal care.

 

This leaflet is intended for informational purposes only and should not replace professional medical advice. Please consult your healthcare provider for any questions or concerns regarding your health or treatment options.